Nycomed
-
Takeda completes acquisition and names new CEO of Nycomed
Transaction fits in with Takeda's sustainable growth strategy.
Nycomed | 30 September 2011
-
Nycomed and Almirall announce a licensing agreement for ebastine in China and other key Southeast Asia markets
• With this agreement, Almirall extends the global reach of the product, present now in more than 30 countries worldwide.
Nycomed | 29 September 2011
-
Nycomed to market Roche's osteoporosis treatment in Asia Pacific
Nycomed announced that it has completed the transfer of marketing authorization approvals in a number of key Asia Pacific markets for osteoporosis treatment Bonviva (Ibandronate). According to the company, the licensing agreement with Roche marks a f…
Nycomed | 15 June 2011
-
Takeda to acquire Nycomed
Takeda Pharmaceutical Company Limited has reached an agreement with the shareholders of Nycomed A/S in which Takeda will acquire the Zurich-headquartered company for 9.6 billion Euro on a cash-free, debt-free basis. The boards of directors of each co…
Nycomed | 23 May 2011
-
Nycomed and Merck & Co Announce Commercialization Agreements in Europe and Canada
Nycomed and Merck & Co have entered into a co-promotion agreement for Canada and certain European countries for the commercialization of Daxas (roflumilast), an investigational once-daily tablet for patients with Chronic Obstructive Pulmonary Disease…
Nycomed | 29 April 2010
-
Nycomed to Acquire Local Portfolio from Sanofi-Aventis and Zentiva
Nycomed has agreed with Sanofi-Aventis and Zentiva to purchase 20 branded generic products in several Central and Eastern European countries. The agreement will strengthen the former’s market position especially in the Czech Republic and Slova…
Nycomed | 01 September 2009
-
Nycomed Intends To Move Chemical Production To Indian Joint Venture
Nycomed and Cadila Healthcare have signed a letter agreement with the intent to amend their existing joint venture agreement to include the chemical production of active pharmaceutical ingredients (APIs) by the joint venture company Zydus Nycomed in …
Nycomed | 31 March 2008
-
Multi-Year Contract Extension With Nycomed For Genedata Screener
Genedata, a leading provider of in silico solutions for drug discovery, has announced a multi-year contract extension for the use of the Genedata Screener lead discovery product suite with Nycomed, a global manufacturer of innovative pharmaceuticals.…
Nycomed | 17 January 2008
